Rescue of Drug-Induced Long QT Syndrome Type 2 Using a HERG Channel Activator in Human Pluripotent Stem Cell-Derived Cardiomyocytes.

被引：0
|
作者：
Macri, Vincenzo S. [1 ]
Norberg, Jessica [1 ]
Hills, Mark [1 ]
Thomas, Terry [1 ]
Eaves, Allen [1 ]
Szilvassy, Stephen J. [1 ]
Louis, Sharon [1 ]
机构：
[1] Stemcell Technol, Rsch & Dev, Vancouver, BC, Canada
来源：
CIRCULATION | 2018年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12042
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Modeling Drug-Induced Long QT Syndrome with Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Stillitano, Francesca
    Kong, Marco
    Karakikes, Ioannis
    Funck-Brentano, Christian
    Reynier, Stephan
    Ma, Wu
    Laurent, Emilie
    Papadopoulos, Aurelie
    Valogne, Yannick
    Desseaux, Carole
    Zahr, Noel
    Li, Ronald
    Hajjar, Roger J.
    Hulot, Jean-Sebastien
    [J]. CIRCULATION, 2014, 130
  • [2] Modeling Drug-Induced Long QT Syndrome with Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Stillitano, Francesca
    Karakikes, Ioannis
    Kong, Chi-wai
    Martinelli, Brett
    Li, Ronald
    Hajjar, Roger J.
    Hulot, Jean-Sebastien
    [J]. CIRCULATION RESEARCH, 2013, 113 (04)
  • [3] A Novel Approach for Evaluation of Drug-Induced QT Prolongation using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Li, Min
    Kanda, Yasunari
    Sekino, Yuko
    Furukawa, Tetsushi
    Kurokawa, Junko
    [J]. BIOPHYSICAL JOURNAL, 2014, 106 (02) : 720A - 721A
  • [4] Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Guo, Liang
    Abrams, Rory M. C.
    Babiarz, Joshua E.
    Cohen, Jennifer D.
    Kameoka, Sei
    Sanders, Martin J.
    Chiao, Eric
    Kolaja, Kyle L.
    [J]. TOXICOLOGICAL SCIENCES, 2011, 123 (01) : 281 - 289
  • [5] Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    El-Battrawy, Ibrahim
    Lan, Huan
    Cyganek, Lukas
    Zhao, Zhihan
    Li, Xin
    Buljubasic, Fanis
    Lang, Siegfried
    Yucel, Gokhan
    Sattler, Katherine
    Zimmermann, Wolfram-Hubertus
    Utikal, Jochen
    Wieland, Thomas
    Ravens, Ursula
    Borggrefe, Martin
    Zhou, Xiao-Bo
    Akin, Ibrahim
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (07):
  • [6] Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
    Schwach, Verena
    Slaats, Rolf H.
    Passier, Robert
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [7] Drug Testing in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
    Zhao, Zhihan
    Li, Xin
    El-Battrawy, Ibrahim
    Lan, Huan
    Zhong, Rujia
    Xu, Qiang
    Huang, Mengying
    Liao, Zhenxing
    Lang, Siegfried
    Zimmermann, Wolfram-Hubertus
    Cyganek, Lukas
    Wieland, Thomas
    Akin, Ibrahim
    Zhou, Xiao-Bo
    Borggrefe, Martin
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (03) : 642 - 651
  • [8] Electrophysiological characterization of human induced pluripotent stem cell derived cardiomyocytes with long QT syndrome type 3
    Malan, D.
    Zhang, M.
    Schulze-Bahr, E.
    Fleischmann, B. K.
    Greber, B.
    Sasse, P.
    [J]. ACTA PHYSIOLOGICA, 2015, 213 : 114 - 114
  • [9] Re-trafficking of hERG reverses Long QT Syndrome 2 phenotype in human pluripotent stem cell derived cardiomyocytes
    Mehta, A.
    Sequiera, G. L.
    Ramachandra, C. J. A.
    Sudibyo, Y.
    Chung, Y. Y.
    Wong, Y. W.
    Tan, T. H.
    Liew, R.
    Wong, P.
    Shim, W.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 276 - 276
  • [10] Drug-testing using human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome
    Zhao, Z.
    Lan, H.
    Li, X.
    El-Battrawy, I.
    Xu, Q.
    Huang, M.
    Zhong, R.
    Liao, Z.
    Lang, S.
    Cyganek, L.
    Zimmermann, W. H.
    Wieland, T.
    Borggrefe, M.
    Zhou, X. B.
    Akin, I.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 600 - 600
12345